Financhill
Buy
53

IQV Quote, Financials, Valuation and Earnings

Last price:
$231.15
Seasonality move :
0.37%
Day range:
$226.57 - $231.75
52-week range:
$134.65 - $247.05
Dividend yield:
0%
P/E ratio:
31.74x
P/S ratio:
2.56x
P/B ratio:
6.39x
Volume:
806.2K
Avg. volume:
1.2M
1-year change:
14.83%
Market cap:
$39.4B
Revenue:
$15.4B
EPS (TTM):
$7.28

Analysts' Opinion

  • Consensus Rating
    IQVIA Holdings, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 16 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $261.15, IQVIA Holdings, Inc. has an estimated upside of 12.94% from its current price of $231.23.
  • Price Target Downside
    According to analysts, the lowest downside price target is $230.00 representing 100% downside risk from its current price of $231.23.

Fair Value

  • According to the consensus of 21 analysts, IQVIA Holdings, Inc. has 12.94% upside to fair value with a price target of $261.15 per share.

IQV vs. S&P 500

  • Over the past 5 trading days, IQVIA Holdings, Inc. has underperformed the S&P 500 by -3.4% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • IQVIA Holdings, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • IQVIA Holdings, Inc. has grown year-over-year revenues for 21 quarters straight. In the most recent quarter IQVIA Holdings, Inc. reported revenues of $4.1B.

Earnings Growth

  • IQVIA Holdings, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter IQVIA Holdings, Inc. reported earnings per share of $1.93.
Enterprise value:
52.7B
EV / Invested capital:
--
Price / LTM sales:
2.56x
EV / EBIT:
23.36x
EV / Revenue:
3.32x
PEG ratio (5yr expected):
93.43x
EV / Free cash flow:
23.85x
Price / Operating cash flow:
18.38x
Enterprise value / EBITDA:
15.57x
Gross Profit (TTM):
$4.2B
Return On Assets:
4.63%
Net Income Margin (TTM):
8.07%
Return On Equity:
20.65%
Return On Invested Capital:
6.13%
Operating Margin:
13.96%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $14.8B $15.3B $15.9B $3.9B $4.1B
Gross Profit $4B $4.3B $4.2B $1.1B $1.1B
Operating Income $1.9B $2.2B $2.3B $575M $572M
EBITDA $3.1B $3.3B $3.4B $853M $858M
Diluted EPS $5.96 $7.62 $7.28 $1.55 $1.93
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $4.5B $4.8B $5.2B $5.6B $6B
Total Assets $24B $24.2B $26B $27.2B $28.7B
Current Liabilities $4.8B $5.3B $6.6B $7B $8.5B
Total Liabilities $18.2B $18.9B $20.2B $20.2B $22.4B
Total Equity $5.8B $5.3B $5.8B $7B $6.3B
Total Debt $12.5B $12.7B $13.8B $13.7B $15.2B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $2B $2.6B $2.8B $721M $908M
Cash From Investing -$1.9B -$1.3B -$1.5B -$599M -$550M
Cash From Financing -$155M -$923M -$1.1B -$137M -$572M
Free Cash Flow $1.3B $2B $2.2B $571M $772M
IQV
Sector
Market Cap
$39.4B
$24M
Price % of 52-Week High
93.6%
50%
Dividend Yield
0%
0%
Shareholder Yield
5.67%
-1.68%
1-Year Price Total Return
14.83%
-21.15%
Beta (5-Year)
1.367
0.502
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $236.45
200-day SMA
Buy
Level $190.92
Bollinger Bands (100)
Buy
Level 199.75 - 234.37
Chaikin Money Flow
Sell
Level -715K
20-day SMA
Sell
Level $238.72
Relative Strength Index (RSI14)
Sell
Level 45.45
ADX Line
Sell
Level 19.93
Williams %R
Neutral
Level -74.4658
50-day SMA
Buy
Level $230.37
MACD (12, 26)
Buy
Level 43.61
25-day Aroon Oscillator
Buy
Level 16
On Balance Volume
Sell
Level -2.1M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.1131)
Sell
CA Score (Annual)
Level (-1.1098)
Buy
Beneish M-Score (Annual)
Level (-2.766)
Buy
Momentum Score
Level (7)
Sell
Ohlson Score
Level (0.7564)
Buy
Piotroski F Score (Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

Stock Forecast FAQ

In the current month, IQV has received 16 Buy ratings 5 Hold ratings, and 0 Sell ratings. The IQV average analyst price target in the past 3 months is $261.15.

  • Where Will IQVIA Holdings, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that IQVIA Holdings, Inc. share price will rise to $261.15 per share over the next 12 months.

  • What Do Analysts Say About IQVIA Holdings, Inc.?

    Analysts are divided on their view about IQVIA Holdings, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that IQVIA Holdings, Inc. is a Sell and believe this share price will drop from its current level to $230.00.

  • What Is IQVIA Holdings, Inc.'s Price Target?

    The price target for IQVIA Holdings, Inc. over the next 1-year time period is forecast to be $261.15 according to 21 Wall Street analysts, 16 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.

  • Is IQV A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for IQVIA Holdings, Inc. is a Buy. 16 of 21 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of IQV?

    You can purchase shares of IQVIA Holdings, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase IQVIA Holdings, Inc. shares.

  • What Is The IQVIA Holdings, Inc. Share Price Today?

    IQVIA Holdings, Inc. was last trading at $231.15 per share. This represents the most recent stock quote for IQVIA Holdings, Inc.. Yesterday, IQVIA Holdings, Inc. closed at $231.23 per share.

  • How To Buy IQVIA Holdings, Inc. Stock Online?

    In order to purchase IQVIA Holdings, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How Big Will the SpaceX IPO Be?
How Big Will the SpaceX IPO Be?

Operated up to now as a private business, SpaceX will…

Where Will ISRG Stock Be in 5 Years?
Where Will ISRG Stock Be in 5 Years?

Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…

Is Kratos Stock a Good Investment?
Is Kratos Stock a Good Investment?

UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 43x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 43x

Alerts

Sell
49
HYMC alert for Feb 3

Hycroft Mining Holding Corp. [HYMC] is up 7.92% over the past day.

Buy
67
FBRX alert for Feb 3

Forte Biosciences, Inc. [FBRX] is up 0.75% over the past day.

Buy
72
BNR alert for Feb 3

Burning Rock Biotech Ltd. [BNR] is down 4.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock